Paul O'Brien to Cost-Benefit Analysis
This is a "connection" page, showing publications Paul O'Brien has written about Cost-Benefit Analysis.
Connection Strength
0.169
-
Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care. 2009 Apr; 32(4):567-74.
Score: 0.069
-
Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabetes Care. 2009 Apr; 32(4):580-4.
Score: 0.069
-
Cost-effectiveness of gastric band surgery for overweight but not obese adults with type 2 diabetes in the U.S. J Diabetes Complications. 2017 Jul; 31(7):1139-1144.
Score: 0.031